Carmen Cepeda Franco

Title: Carmen Cepeda Franco: Innovator in Hemostatic Technology

Introduction

Carmen Cepeda Franco is a notable inventor based in Seville, Spain. He has made significant contributions to the field of medical technology, particularly in the development of hemostatic agents. His innovative work focuses on improving surgical outcomes and trauma care through advanced materials.

Latest Patents

Carmen holds a patent for his invention titled "Hemostatic efficacy of a nanostructured fibrin agarose hydrogel." This invention provides a novel approach to managing moderate intraoperative hemorrhage and trauma. The patent describes the use of nanostructured fibrin and agarose hydrogels, specifically type VII agarose hydrogels, as effective hemostatic agents. These hydrogels can be applied topically to wounds, either on the skin during laparotomy or in a non-invasive manner during surgical procedures. The technology behind this hydrogel ensures the rapid formation of a stable fibrin clot, which is crucial for effective hemostasis.

Career Highlights

Carmen has worked with several reputable organizations, including the Fundación Pública Andaluza Progreso y Salud and the Servicio Andaluz de Salud. His experience in these institutions has allowed him to refine his expertise in medical innovations and contribute to advancements in healthcare.

Collaborations

Carmen has collaborated with notable colleagues such as Rafael Campos Cuerva and Beatriz Fernández Muñoz. Their combined efforts in research and development have furthered the impact of his inventions in the medical field.

Conclusion

Carmen Cepeda Franco's contributions to hemostatic technology exemplify the importance of innovation in medicine. His patented hydrogel represents a significant advancement in surgical care, showcasing the potential of nanostructured materials in improving patient outcomes.